CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Successful Treatment of Unprotected Left Main Coronary Bifurcation Lesion Using Minimum Contrast Volume with Intravascular Ultrasound Guidance Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Heart Failure With Preserved Ejection Fraction in the Young The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure Circulating Plasma microRNAs In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study

Original Research2020 Jun 7;128:110336.

JOURNAL:Biomed Pharmacother. Article Link

Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

YN Dai, JL Huang, DQ Yu et al. Keywords: atorvastatin; rosuvastatin; STEMI; PCI; post-contrast acute kidney injury

Full Text PDF